News

You are here

Interreg CrossCare grant allows Novosanis to build a next-generation Colli-Pee™ device
Novosanis develops UrNCollect TM for SelectMDx for Prostate Cancer IVD kit of MDxHealth
Approval of Colli-Pee for commercial use in the US
Novosanis, a medical device company based in Wijnegem Belgium, together with GeneFirst, a molecular diagnostic company based in Oxfordshire UK, announced CE Marking and launch of...

Pages